Literature DB >> 3771801

In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia.

G L Vega, S M Grundy.   

Abstract

The causes of primary moderate hypercholesterolemia are not understood, but some patients have reduced fractional clearance rates (FCRs) for low density lipoproteins (LDL). This could be due to either decreased activity of LDL receptors or to a defect in structure (or composition) of LDL that reduces its affinity for receptors. To distinguish between these causes, simultaneous turnover rates of autologous and normal homologous LDL were determined in 15 patients with primary moderate hypercholesterolemia. In 10, turnover rates of both types of LDL were indistinguishable, which indicated that autologous LDL was cleared as efficiently as normal homologous LDL. In five others, FCRs for autologous LDL were significantly lower than for homologous LDL. Two of the latter five were treated with mevinolin, and although FCRs for both types of LDL rose during treatment, differences in FCRs between the two types of LDL persisted. In these five patients, autologous LDL appeared to be a poor ligand for LDL receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771801      PMCID: PMC423848          DOI: 10.1172/JCI112729

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

2.  The metabolism of the apoprotein of plasma low density lipoprotein in familial hyperbetalipoproteinaemia in the homozygous form.

Authors:  L A Simons; D Reichl; N B Myant; M Mancini
Journal:  Atherosclerosis       Date:  1975 Mar-Apr       Impact factor: 5.162

3.  Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

Authors:  J S McDougal; S P Cort; M S Kennedy; C D Cabridilla; P M Feorino; D P Francis; D Hicks; V S Kalyanaraman; L S Martin
Journal:  J Immunol Methods       Date:  1985-01-21       Impact factor: 2.303

4.  RFLP for the human apolipoprotein B gene: I;BamHI.

Authors:  L Priestley; T Knott; S Wallis; L Powell; R Pease; A Simon; J Scott
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

5.  Kinetic mechanisms determining variability in low density lipoprotein levels and rise with age.

Authors:  S M Grundy; G L Vega; D W Bilheimer
Journal:  Arteriosclerosis       Date:  1985 Nov-Dec

6.  Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.

Authors:  G Heiss; I Tamir; C E Davis; H A Tyroler; B M Rifkand; G Schonfeld; D Jacobs; I D Frantz
Journal:  Circulation       Date:  1980-02       Impact factor: 29.690

7.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.

Authors:  K H Weisgraber; S C Rall; R W Mahley
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

8.  Familial hypercholesterolemia with "normal" cholesterol in obligate heterozygotes.

Authors:  J J Nora; R M Lortscher; R D Spangler; D W Bilheimer
Journal:  Am J Med Genet       Date:  1985-11

9.  Increased low density lipoprotein production associated with obesity.

Authors:  Y A Kesaniemi; S M Grundy
Journal:  Arteriosclerosis       Date:  1983 Mar-Apr

10.  The human apolipoprotein B-100 gene: a highly polymorphic gene that maps to the short arm of chromosome 2.

Authors:  L Chan; P VanTuinen; D H Ledbetter; S P Daiger; A M Gotto; S H Chen
Journal:  Biochem Biophys Res Commun       Date:  1985-11-27       Impact factor: 3.575

View more
  33 in total

1.  Autosomal recessive hypercholesterolaemia in a Morrocan family due to a mutation of the G266C LDL receptor.

Authors:  Siham El Aziz; Asma Chadli; Hassan El Ghomari; Ahmed Farouqi
Journal:  BMJ Case Rep       Date:  2012-05-23

Review 2.  Human CYP7A1 deficiency: progress and enigmas.

Authors:  Anne Beigneux; Alan F Hofmann; Stephen G Young
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 3.  Monogenic hypercholesterolemia: new insights in pathogenesis and treatment.

Authors:  Daniel J Rader; Jonathan Cohen; Helen H Hobbs
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

4.  First International Workshop on Familial Defective apo B-100, Munich, November 1991.

Authors:  H Schuster; S Humphries; G Rauh; C Keller
Journal:  Clin Investig       Date:  1992-10

Review 5.  Genetic basis of lipoprotein disorders.

Authors:  J L Breslow
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

6.  Probing of the expression of the low-density lipoprotein receptor in vivo using an anti-receptor monoclonal antibody.

Authors:  E Gherardi; D E Bowyer; C Fitzsimmons; T Le Cras; A Hutchings; G Butcher
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

7.  Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach.

Authors:  L Berglund; J L Witztum; N F Galeano; A S Khouw; H N Ginsberg; R Ramakrishnan
Journal:  J Lipid Res       Date:  1998-04       Impact factor: 5.922

8.  Novel gene-by-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol.

Authors:  Daniel S Kim; Amber A Burt; Jane E Ranchalis; Ella R Jarvik; Elisabeth A Rosenthal; Thomas S Hatsukami; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2013-03-11       Impact factor: 5.922

9.  Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients.

Authors:  M R Lovati; C Manzoni; A Canavesi; M Sirtori; V Vaccarino; M Marchi; G Gaddi; C R Sirtori
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

10.  Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.

Authors:  T L Innerarity; K H Weisgraber; K S Arnold; R W Mahley; R M Krauss; G L Vega; S M Grundy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.